Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member

Biochemical and Biophysical Research Communications

Volumn 276, Issue 3, 2000, Pages 1170-1177

  McKenzie, Edward ^a   Tyson, Kerry ^a   Stamps, Alasdair ^a   Smith, Paul ^a   Turner, Paul ^a   Barry, Richard ^a   Hircock, Margaret ^a   Patel, Sonal ^a   Barry, Eleanor ^a   Stubberfield, Colin ^a   Terrett, Jon ^a   Page, Martin ^a  

^a Oxford GlycoSciences   (United Kingdom)

Author keywords

Cancer; Chromosomal localization; Heparanase; Homologue; Inflammation; mRNA distribution; Novel

Indexed keywords

HEPARANASE; PROTEIN HPA2; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER TISSUE; CHROMOSOMAL LOCALIZATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR CELL;

EID: 0034610010     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3586     Document Type: Article

References (42)

1. Purification and properties of human platelet heparitinase
2. Activated T-lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase
3. Human mononuclear cells contain an endoglycosidase specific for heparan sulfate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate
4. Substrate specificity of a heparan sulfate-degrading endoglucuronidase from human placents
5. Human prostate carcinoma cells produce extracellular heparanase
6. Heparanase activity in cultured endothelial cells
7. Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein
8. Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: Relationship to tumor cell metastasis
9. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation
10. Heparan sulfate degradation: Relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines
11. Inhibition of tumor metastasis by heparanase inhibiting species of heparin
12. Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor cell-derived heparanase
13. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity
14. Treatment of central nervous system inflammation with inhibitors of basement membrane degradation
15. Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides
16. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins
17. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity
18. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
19. Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis
20. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products
21. Recycling of a glycophosphatidylinositol-anchored heparan sulphate proteoglycan (glypican) in skin fibroblasts
22. Glypican (heparan sulphate proteoglycan) is palmitoylated, deglycanated and reglycanated during recycling in skin fibroblasts
23. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence, of fibrillar A beta-amyloid in rat brain
24. Immunochemical localization of heparanase in mouse and human melanomas
25. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes
26. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts
27. Human platelet heparanase: Purification, characterization and catalytic activity
28. Partial purification of heparanase activities in Chinese hamster ovary cells: Evidence for multiple intracellular heparanases
29. Substrate specificity of heparanases from human hepatoma and platelets
30. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
31. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
32. Cloning and functional expression of a human heparanase gene
33. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer
34. Molecular modelling of protein-glycosaminoglycan interactions
35. Real time quantitative PCR
36. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer
37. Molecular cloning of a novel human PAPS synthetase which is differentially expressed in metastatic and non-metastatic colon carcinoma cells
38. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: Gene cloning, characterization and chromosomal localization
39. Human HPA endoglycosidase heparanase. Map position 4q21.3
40. Heparanase expression in invasive trophoblasts and acute vascular damage
41. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans
42. Aβ(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro: A role for heparan sulfate proteoglycan turnover in Alzheimer's disease